🇺🇸 FDA
Patent

US 9233927

Crystals of laquinimod sodium and improved process for the manufacture thereof

granted A61KA61K31/47A61P

Quick answer

US patent 9233927 (Crystals of laquinimod sodium and improved process for the manufacture thereof) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Jan 12 2016 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 07 2036 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
22
CPC classes
A61K, A61K31/47, A61P, A61P1/04, A61P13/12